Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Uniform Quality Standards for a Quarter of a Century

Published: Wednesday, February 27, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
SCHOTT Tubing has been publishing technical delivery specifications for pharmaceutical tubing for 25 years.

The international technology group SCHOTT has been documenting and publishing technical terms of supply for its glass tubing for use in pharmaceutical applications for 25 years now.

In fact, SCHOTT became the first company in the industry to provide its customers with exact specifications of the most important product parameters in 1988.

Since then, the ongoing improvements that have been made to its special glass tubing used to produce vials, syringes, cartridges and ampoules have been anchored in its terms of supply and thus made visible for its customers.

SCHOTT constantly strives to make improvements that flow into its quality standards to accommodate changing market demands, the needs of its customers and its own goal of providing its customers with maximum benefits.

A revised version of its technical delivery specifications is published about every three years.

“At SCHOTT Tubing, we have been setting the standards on manufacturing glass tubing for 25 years with our technical terms of supply. This means we are committed to constantly improving our production process and offer our customers the highest possible transparency and quality assurance,” says Jürgen Achatz, Global Sales Director for Pharmaceutical Tubing at SCHOTT.

In addition to a description of the products in which all of the characteristics of relevance to its customers are defined in great detail, the technical delivery specifications also include precisely determined tolerance ranges.

SCHOTT’s delivery specifications differ from its competitors’ technical terms of delivery not only in terms of their vast depth of detail and clarity.

The company also subjects its specification to further review by the Federal Association of the German Glass Industry.

The specialized group “Primary Packaging” discusses and evaluates the company’s standards, whereby the results flow directly into the final version of the delivery specifications.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCHOTT Launches New Center of Excellence for RTU Pharma Packaging
Initiative will more closely tie together SCHOTT’s experts and pharma partners as production of adaptiQ® ready-to-use vials commences.
Saturday, October 24, 2015
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!